Abstract
Metal nanoparticles (NPs) have been reduced with NaBH4 from Pt, Rh and Ir precursors salts in presence of (2R,4R)-2,4- bis(diphenylphosphino pentane), ((R,R)-BDPP), and SiO2. This synthesis procedure with a chiral ligand generates chiral stabilized NPs of small and narrowly distributed core sizes depending of metal precursor, metallic loading and ligand stabilizer concentration. These novel catalysts with chiral surface have been used in enantioselective hydrogenation of ethyl pyruvate as a reference substrate and 1-phenylpropane- 1,2-dione, acetophenone, 2,3-butanedione and 3,4-hexanedione, all scarcely studied ketones. Catalysts were characterized by TEM, EDS, electron diffraction, N2 adsorption-desorption isotherms and XPS.
Catalytic results indicate high conversion levels and enantioselectivities up to 78% in the hydrogenation of some substrates, due to the presence of chiral ligand on metal surface. All results are promising because is the first report of high enantiomeric excess (ee) in hydrogenations using these kind of heterogeneous catalytic systems.
Keywords: Chiral surface, Colloids immobilization, Enantioselective hydrogenation, Metal nanoparticles.
Current Organic Chemistry
Title:Novel Metal Nanoparticles Stabilized with (2R,4R)-2,4-bis(diphenylphosphino) Pentane on SiO2. Their Use as Catalysts in Enantioselective Hydrogenation Reactions
Volume: 16 Issue: 23
Author(s): Doris Ruiz, Marcelo Oportus, Cyril Godard, Carmen Claver, Jose Luis G. Fierro and Patricio Reyes
Affiliation:
Keywords: Chiral surface, Colloids immobilization, Enantioselective hydrogenation, Metal nanoparticles.
Abstract: Metal nanoparticles (NPs) have been reduced with NaBH4 from Pt, Rh and Ir precursors salts in presence of (2R,4R)-2,4- bis(diphenylphosphino pentane), ((R,R)-BDPP), and SiO2. This synthesis procedure with a chiral ligand generates chiral stabilized NPs of small and narrowly distributed core sizes depending of metal precursor, metallic loading and ligand stabilizer concentration. These novel catalysts with chiral surface have been used in enantioselective hydrogenation of ethyl pyruvate as a reference substrate and 1-phenylpropane- 1,2-dione, acetophenone, 2,3-butanedione and 3,4-hexanedione, all scarcely studied ketones. Catalysts were characterized by TEM, EDS, electron diffraction, N2 adsorption-desorption isotherms and XPS.
Catalytic results indicate high conversion levels and enantioselectivities up to 78% in the hydrogenation of some substrates, due to the presence of chiral ligand on metal surface. All results are promising because is the first report of high enantiomeric excess (ee) in hydrogenations using these kind of heterogeneous catalytic systems.
Export Options
About this article
Cite this article as:
Ruiz Doris, Oportus Marcelo, Godard Cyril, Claver Carmen, G. Fierro Luis Jose and Reyes Patricio, Novel Metal Nanoparticles Stabilized with (2R,4R)-2,4-bis(diphenylphosphino) Pentane on SiO2. Their Use as Catalysts in Enantioselective Hydrogenation Reactions, Current Organic Chemistry 2012; 16 (23) . https://dx.doi.org/10.2174/138527212804546804
DOI https://dx.doi.org/10.2174/138527212804546804 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Inflammation-Mediating Proteases: Structure, Function in (Patho) Physiology and Inhibition
Protein & Peptide Letters Echocardiographic Hemodynamic Monitoring in the Critically Ill Patient
Current Cardiology Reviews New Developments in Systemic Therapy for Hepatocellular Carcinoma
Current Cancer Therapy Reviews Bradykinin Antagonists as Anti-Cancer Agents
Current Pharmaceutical Design Diet and Heart Health: Moderate Wine Drinking Strengthens the Cardioprotective Effects of Fish Consumption
Current Pharmaceutical Biotechnology Prevention of Atherosclerosis by Interference with the Vascular Nitric Oxide System
Current Pharmaceutical Design Treatment of Diabetic Foot Ulcers
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Adverse Drug Reactions in Hospitals: A Narrative Review
Current Drug Safety Pathogenesis of Acute Kidney Injury During Sepsis
Current Drug Targets Functional Neuroanatomy of the Noradrenergic Locus Coeruleus: Its Roles in the Regulation of Arousal and Autonomic Function Part I: Principles of Functional Organisation
Current Neuropharmacology Paraneoplastic Neurological Syndromes - Diagnosis and Management
Current Pharmaceutical Design Cardiovascular Pharmacogenetics of Antihypertensive and Lipid- Lowering Therapies
Current Molecular Medicine In vitro and in silico Evaluation of Non-Quaternary Reactivators of AChE as Antidotes of Organophosphorus Poisoning - a New Hope or a Blind Alley?
Medicinal Chemistry A Catalytically Inactive Lys49 PLA2 Isoform from Bothrops jararacussu venom that Stimulates Insulin Secretion in Pancreatic Beta Cells
Protein & Peptide Letters Piribedil: Antiparkinsonian Properties and Potential Clinical Utility in Dopaminergic Disorders
Current Drug Therapy Pathophysiology and Treatment of Obesity Hypertension
Current Pharmaceutical Design The Hypothalamic-Neurohypophyseal System: Current and Future Treatment of Vasopressin and Oxytocyn Related Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Biologicals Dramatic Advances in the Treatment of Psoriasis
Current Pharmaceutical Design Radiolabeled Compounds in Diagnosis of Infectious and Inflammatory Disease
Current Pharmaceutical Design A Role for Leptin in the Systemic Inflammatory Response Syndrome (SIRS) and in Immune Response, an Update
Current Medicinal Chemistry